PCR test for COVID-19 in 1.5 hours

Lukina Galina Viktorovna

Lukina Galina Viktorovna


  • II-th MOLGMI named after N. I. Pirogov, specialty medical science
  • Clinical residency at the Institute of Rheumatology of the Russian Academy of Medical Sciences
  • Full-time postgraduate study at the Institute of Rheumatology of the Russian Academy of Medical Sciences.  

PhD thesis: "Features of the development of secondary amyloidosis in patients with rheumatic diseases and evaluation of modern methods of its therapy"".

Doctoral dissertation: "Anti-cytokine therapy for rheumatoid arthritis".

Experience: rheumatologist of the highest category, 25 years of experience in the specialty.

Titles: doctor of Medical Sciences, Professor, specialty " Rheumatology»

Main activities: treatment of rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, genetic engineering biological therapy of rheumatic diseases, which was first applied in Russia in 1996.

Member of the Association of Rheumatologists of Russia and the Editorial Board of the journal "Medical Alphabet".

Scientific supervisor of 7 defended PhD theses.

International activities:

Chief Coordinator of the Russian Register of Genetically Engineered Biological Drugs ARBITER and representative of Russia in the European Cooperation of the registers of rituximab (CERERRA), tocilizumab (TOCERRA). tofacitinib (JAK-POT).

Member of the Expert Committees on Rheumatology AbbVie, Bristol-Myers Squibb, Lilly, MSD, Pfizer, Roche, UCB.

Publications: 360 published scientific works, including 6 monographs "Base (pathogenic) therapy of rheumatoid arthritis" (2000), "Rheumatoid arthritis" (2001), "Biological treatment in rheumatology" (2007, 2009), "Anti-b-cell therapy in rheumatology: focus on rituximab" (2012), "Genetically engineered biological drugs in the treatment of rheumatoid arthritis" (2013), and one patent for invention.

GBUZ Moscow Clinical Scientific Center named after Loginov MHD